Skip to main content
. 2021 Dec 1;4(6):1849–1866. doi: 10.1021/acsptsci.1c00226

Table 6. MDA-MB-231 versus SKBR3 Selectivity of the Best 2-Sulfonylpyrimidine/2-Thiopyrimidine Derivatives.

  IC50 (μM) [95% CI]
 
cpd MDA-MB-231 SKBR3 cell selectivity ratio (IC50 SKBR3/IC50 MDA-MB-231)
C9 48 [43–53] ∼69 ∼1.4
C9.12 17 [15–19] 23 [22–26] 1.4
C9.19 6 [6–7] ∼13 ∼2.2
C9.20 ∼28 ∼29 ∼1.0
C9.22 4.2 [4.0–4.4] ∼13 ∼3.1
C9.24 105 [73–172] >200 >1.9
C9.25 180 [73–??] >400 >2.2
CB-839 0.038 [0.031–0.048] >1 >26